Perella Weinberg Partners 8-K

What Happened

• Perella Weinberg Partners (the Company) entered into a Sale and Purchase Deed on April 13, 2026 to acquire 100% of the membership interests of a limited liability partnership organized in England and Wales. The closing is expected in the second half of 2026 and is subject to customary conditions, including required regulatory approvals.
• As partial consideration, the Company agreed to issue Class A common stock: 1,127,529 shares at closing; 2,255,058 additional shares to be issued in three annual tranches on each of the first, second and third anniversaries of closing (subject to forfeiture in certain circumstances); and additional contingent consideration tied to fees from certain client engagements, a portion of which may be paid in shares based on the volume-weighted average price (VWAP) during specified measurement periods.

Key Details

• Transaction signed: April 13, 2026; expected close: second half of 2026 (subject to regulatory approvals).
• Upfront shares at closing: 1,127,529; tranches: 2,255,058 shares (issued over three anniversaries); total fixed-share consideration = 3,382,587 shares.
• Contingent consideration: variable, based on fees from certain client engagements; some may be paid in Common Stock calculated using VWAP during defined periods.
• Securities treatment: shares will be unregistered and issued relying on Section 4(a)(2) (private placement); issued shares will be "restricted securities" under Rule 144. The Company has agreed to file a registration statement (or supplement) to permit resales, or resales may occur under exemptions.

Why It Matters

• Investors should note the issuance increases the number of outstanding Class A shares by at least ~3.38 million when all tranches are issued, with potential further dilution if contingent consideration is paid in stock. The filing does not provide a pro forma share count, so the exact dilution percentage isn’t disclosed here.
• The shares will initially be restricted and the Company plans to register them for resale (or rely on exemptions), which could introduce future selling supply into the market once registration takes effect or exemptions are used.
• Closing remains subject to regulatory approvals and customary conditions, so the transaction—and the related share issuances—are not final until those conditions are satisfied.